Novel therapy with 2-methoxyestradiol for the treatment of relapsed and plateau phase multiple myeloma.
about
Microtubule-binding agents: a dynamic field of cancer therapeutics.ELR510444 inhibits tumor growth and angiogenesis by abrogating HIF activity and disrupting microtubules in renal cell carcinoma2-Methoxyestradiol ameliorates glucose tolerance with the increase in β-cell mass in db/db mice.Phase I trial of 2-methoxyestradiol NanoCrystal dispersion in advanced solid malignancies.Therapeutic efficacy of 2-methoxyestradiol microcrystals encapsulated within polyelectrolyte multilayersNongenomic inhibition of coronary constriction by 17ß-estradiol, 2-hydroxyestradiol, and 2-methoxyestradiol.Influence of dendrimer surface charge on the bioactivity of 2-methoxyestradiol complexed with dendrimers.Therapeutic promises of 2-methoxyestradiol and its drug disposition challengesELR510444, a novel microtubule disruptor with multiple mechanisms of actionIntra-Laboratory Pre-Validation of a Human Cell Based in vitro Angiogenesis Assay for Testing Angiogenesis Modulators.Mitochondrial peroxiredoxin III is a potential target for cancer therapyEzrin, radixin, and moesin are phosphorylated in response to 2-methoxyestradiol and modulate endothelial hyperpermeability.DNA strand breaks induced by nuclear hijacking of neuronal NOS as an anti-cancer effect of 2-methoxyestradiolAssessing the regioselectivity of OleD-catalyzed glycosylation with a diverse set of acceptors.Identification of an ABCB1 (P-glycoprotein)-positive carfilzomib-resistant myeloma subpopulation by the pluripotent stem cell fluorescent dye CDy1Critical role of cyclin B1/Cdc2 up-regulation in the induction of mitotic prometaphase arrest in human breast cancer cells treated with 2-methoxyestradiol.Tumor vasculature as target for therapeutic intervention.Manipulation of cellular redox parameters for improving therapeutic responses in B-cell lymphoma and multiple myeloma.Theoretical and computational studies of dendrimers as delivery vectors.Effects of 2-methoxyestradiol on apoptosis and HIF-1α and HIF-2α expression in lung cancer cells under normoxia and hypoxia.2ME2 inhibits the activated hypoxia-inducible pathways by cabozantinib and enhances its efficacy against medullary thyroid carcinoma.Neuronal nitric oxide synthase induction in the antitumorigenic and neurotoxic effects of 2-methoxyestradiol.Taxol alleviates 2-methoxyestradiol-induced endothelial permeability.
P2860
Q27690249-A9F39908-D896-40E9-88B4-559AB7E2A75DQ28479196-34547336-B3F9-4816-A197-70C04B9EC8BFQ33585615-3278A4D4-8122-4A0B-8027-1BE00F936796Q33942951-8C05E1DB-63E6-41B9-9BA1-7D62429F5071Q33983838-AA10DCBB-A8E5-46C1-9BD3-3DD5ADE64654Q34021692-0359B191-5F42-4EF7-8ED3-C082E38A6A11Q34135619-7C80F029-C154-4D2E-9C3F-7BAFE5968C10Q34691671-46DA7682-AB2B-4B70-A333-EAAE4D1A7D77Q34702388-53544605-2AE1-45E8-B926-936AF77196BDQ35100891-335424B0-88DC-4C71-BD9E-1AEF3CBD9D2CQ35536098-99D7389C-A63B-4A9C-9905-4707A9CC4AA5Q35684785-094B89E5-982A-4DD2-B23B-325C627F8749Q36021044-49A59F56-9D23-45EE-B5EC-D567C5BCE494Q36715634-9AB611FA-4C75-4554-BAFC-F5C6D79249F8Q36717999-ADA1976B-0098-4853-A863-C93F9821A244Q37183449-0B7138DF-76D8-4A23-B93F-48C84B14DC18Q37800110-C960EA10-613B-4542-844A-AF6FD3980D72Q37940343-0B15C993-0A72-425F-A0D8-6BE39123998AQ38056805-7BBC231C-2E70-41B6-80CE-A46F19CD5426Q38821162-1A963AEB-78DC-4B79-805C-C4042A9DD425Q38848483-6AD608A1-A574-4B65-98A5-E34719A672C7Q38961781-345112B0-1B5B-4402-AB7F-7CF861105C2DQ40749691-08C7D92B-A447-4801-802C-53DEECEA64E2
P2860
Novel therapy with 2-methoxyestradiol for the treatment of relapsed and plateau phase multiple myeloma.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Novel therapy with 2-methoxyes ...... lateau phase multiple myeloma.
@en
Novel therapy with 2-methoxyes ...... lateau phase multiple myeloma.
@nl
type
label
Novel therapy with 2-methoxyes ...... lateau phase multiple myeloma.
@en
Novel therapy with 2-methoxyes ...... lateau phase multiple myeloma.
@nl
prefLabel
Novel therapy with 2-methoxyes ...... lateau phase multiple myeloma.
@en
Novel therapy with 2-methoxyes ...... lateau phase multiple myeloma.
@nl
P2093
P50
P1476
Novel therapy with 2-methoxyes ...... lateau phase multiple myeloma.
@en
P2093
Carolyn F Sidor
Philip R Greipp
Robert Schlossman
Thomas E Witzig
P304
P356
10.1158/1078-0432.CCR-07-0807
P407
P50
P577
2007-10-01T00:00:00Z